Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
naoluotong
- Development stage
- Unknown
- Lead developer
- Hainan Huluwa Pharmaceutical Group
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Naoluotong is a Traditional Chinese Medicine (TCM) combination product primarily used to improve cerebral circulation and treat symptoms associated with cerebrovascular insufficiency. It is a hybrid formulation that integrates chemical components with herbal extracts. The standard composition includes **methylhesperidin** and **thiamine (Vitamin B1)** alongside extracts from **Salvia miltiorrhiza** (Dan Shen), **Ligusticum chuanxiong** (Chuanxiong), **Astragalus membranaceus** (Huangqi), and **Pueraria lobata** (Gegen). This combination is designed to promote blood circulation, resolve blood stasis, and support neurological health. It is commonly prescribed in China for the treatment of cerebral arteriosclerosis, sequelae of stroke (such as cerebral infarction), and related symptoms including headache, dizziness, and limb numbness. The product is manufactured by several companies, including Guangdong Xinbao Pharmaceutical, and is typically administered in capsule form.
- Brand names
- Naoluotong Jiaonang
- Other names
- 脑络通Naoluotong Capsules脑络通胶囊
02
Targets
F2 (Thrombin)CaV (Voltage-gated calcium channel protein complex)NaV (Voltage-gated sodium channels)
Beyond the preview
Go deeper on naoluotong.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on naoluotong.